Clinical Trial Update: The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating 0.05% cyclosporine eye drops for dry eye disease in diabetic patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Cyclosporine ophthalmic solution 0.05% (cyclosporine ophthalmic solution)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Dry Eye | Phase 4 | Status: COMPLETED